Kailera says obesity pill succeeds in late-stage trial in China | BioPharma Dive
Dive Brief: - Kailera Therapeutics said its GLP-1 pill helped people with obesity in a short Phase 3 trial in China lose around one-tenth of their body weight, giving the newly public biotechnology firm anothe…
Read guide →